Risk factors for craving and relapse in heroin users treated with oral or implant naltrexone
Background: Oral naltrexone effectively antagonizes heroin, but patient noncompliance limits its utility; sustained-release preparations may overcome this. Few data are available on optimal blood naltrexone levels for preventing craving and/or return to heroin use. This study assesses various risk f...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
Elsevier Inc.
2010
|
| Online Access: | http://hdl.handle.net/20.500.11937/5417 |